Biblio Discovery — Demo Discovery Service

7 results for "R. Benjamin Free"

Showing 1–7 · 0.57 seconds · RSS

  1. Journal Article Full text

    The E 2.65 A mutation disrupts dynamic binding poses of SB269652 at the dopamine D2 and D3 receptors

    Ravi Kumar Verma; Ara M. Abramyan; Mayako Michino et al.

    PLOS Computational Biology, Vol. 14 No. 1 · 2018 · English · PLOS Scopus

    The dopamine D2 and D3 receptors (D2R and D3R) are important targets for antipsychotics and for the treatment of drug abuse. SB269652, a bitopic ligand that simultaneously binds both the orthosteric binding site (OBS) and a secondary binding pocket (SBP) in both D2R and D3R, was found to be a…

    Also available at: DOAJ

  2. Journal Article

    Structure-Activity Investigation of a G Protein-Biased Agonist Reveals Molecular Determinants for Biased Signaling of the D2 Dopamine Receptor

    Lani S. Chun; Rakesh H. Vekariya; R. Benjamin Free et al.

    Frontiers in Synaptic Neuroscience, Vol. 10 · 2018 · English · DOAJ Scopus

    The dopamine D2 receptor (D2R) is known to elicit effects through activating two major signaling pathways mediated by either G proteins (Gi/o) or β-arrestins. However, the specific role of each pathway in physiological or therapeutic activities is not known with certainty. One approach to the…

  3. Journal Article Full text

    G Protein-Coupled Receptor Kinase 2 Selectively Enhances β-Arrestin Recruitment to the D2 Dopamine Receptor through Mechanisms That Are Independent of Receptor Phosphorylation

    Marta Sánchez-Soto; Noelia M. Boldizsar; Kayla A. Schardien et al.

    Biomolecules, Vol. 13 No. 10 · 2023 · English · DOAJ Scopus

    The D2 dopamine receptor (D2R) signals through both G proteins and β-arrestins to regulate important physiological processes, such as movement, reward circuitry, emotion, and cognition. β-arrestins are believed to interact with G protein-coupled receptors (GPCRs) at the phosphorylated C-terminal…

  4. Journal Article

    Dual pancreatic adrenergic and dopaminergic signaling as a therapeutic target of bromocriptine

    Despoina Aslanoglou; Suzanne Bertera; Laura Friggeri et al.

    iScience, Vol. 25 No. 8 · 2022 · English · DOAJ Scopus

    Summary: Bromocriptine is approved as a diabetes therapy, yet its therapeutic mechanisms remain unclear. Though bromocriptine’s actions have been mainly attributed to the stimulation of brain dopamine D2 receptors (D2R), bromocriptine also targets the pancreas. Here, we employ bromocriptine as a…

  5. Journal Article

    Dopamine regulates pancreatic glucagon and insulin secretion via adrenergic and dopaminergic receptors

    Despoina Aslanoglou; Suzanne Bertera; Marta Sánchez-Soto et al.

    Translational Psychiatry, Vol. 11 No. 1 · 2021 · English · DOAJ Scopus

    Abstract Dopamine (DA) and norepinephrine (NE) are catecholamines primarily studied in the central nervous system that also act in the pancreas as peripheral regulators of metabolism. Pancreatic catecholamine signaling has also been increasingly implicated as a mechanism responsible for the…